A standard laboratory with ELISA equipment will be able to analyse various sample materials thanks the new Monkey NGAL ELISA Kit, the company added.
The monkey or non-human primate is an essential experimental model for medical research, as it is close to the human physiology.
NGAL is a biomarker that determines acute kidney injury and is often presented as a candidate for the use in pre-clinical testing industry.
Perrigo to acquire United States rights for Entocort from AstraZeneca
US FDA approves Boehringer Ingelheim's Pradaxa
Phase II clinical trial for potential treatment of androgenetic alopecia completed by Samumed
Life Sciences Partners collaborates on immuno-oncology with Bristol-Myers Squibb
Arsanis initiates first cohort in Phase one clinical trial of ASN100
Impax introduces generic Avodart (Dutasteride) Capsules, 0.5 mg
Mylan unveils generic FazaClo orally disintegrating tablets for treating schizophrenia